VanEck Associates’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-70
Closed 1438
2022
Q1
$0 Hold
70
﹤0.01% 1418
2021
Q4
$1K Hold
70
﹤0.01% 1371
2021
Q3
$3K Hold
70
﹤0.01% 1280
2021
Q2
$4K Hold
70
﹤0.01% 1259
2021
Q1
$5K Hold
70
﹤0.01% 1214
2020
Q4
$3K Hold
70
﹤0.01% 1010
2020
Q3
$3K Hold
70
﹤0.01% 1006
2020
Q2
$3K Buy
+70
New +$2.84K ﹤0.01% 993

Other funds holding GTH

VanEck Associates's GTH Position: Q2 2022 in Review

VanEck Associates sold out of Genetron Holdings Limited ADS (GTH) in Q2 2022, closing a stake of 70 shares.

VanEck Associates first reported a position in GTH in Q2 2020 and held it in 8 quarters. The position peaked at $5K in Q1 2021. 34 funds tracked by Wall St. Rank hold GTH as of Q2 2022.

  • VanEck Associates reported no remaining Genetron Holdings Limited ADS position as of Q2 2022 after selling out during the quarter.
  • VanEck Associates sold 70 Genetron Holdings Limited ADS shares in Q2 2022.
  • VanEck Associates first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 8 quarters.
  • VanEck Associates's Genetron Holdings Limited ADS position peaked at $5K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q2 2022.

Based on VanEck Associates's 13F filing for Q2 2022, filed 3 Aug 2022.